For a third time, the New Guyana Pharmaceutical Corporation Inc. (GPC) has successfully completed an audit by the United States Food and Drug Administration (FDA) that allows it to continue exporting its manufactured products to the country.
Speaking with the Sunday Stabroek, General Manager of New GPC, Ravi Ramcharitar, confirmed that the US-FDA had sent a team to do an audit of the company’s operations in October last year and after it was completed, no issues were found that would disqualify them from exporting to the United States of America.
As a result, the company was once again given the greenlight to continue exporting their manufactured drugs.
